Equities

Avalon Globocare Corp

ALBT:NAQ

Avalon Globocare Corp

Actions
Real EstateReal Estate Investment and Services
  • Price (USD)2.65
  • Today's Change-0.13 / -4.68%
  • Shares traded40.06k
  • 1 Year change-66.67%
  • Beta0.2691
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.

  • Revenue in USD (TTM)1.31m
  • Net income in USD-14.73m
  • Incorporated2014
  • Employees5.00
  • Location
    Avalon Globocare Corp4400 ROUTE 9, SUITE 3100FREEHOLD 07728United StatesUSA
  • Phone+1 (732) 780-4400
  • Fax+1 (732) 780-5600
  • Websitehttp://www.avalon-globocare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SPO Global Inc838.00k-540.00k617.35k2.00------0.7367-85.99-85.99131.76-476.561.76-------113.56-305.39----31.1527.31-64.44-384.85---1.45-----17.09-15.1313.03------
Modern Mobility Aids Inc0.00-1.59m1.01m-----------0.0177-0.01770.00-0.0040.00-------4,668.68---------------------------371.94------
Novo Integrated Sciences Inc13.52m-24.33m1.05m127.00--0.1053--0.0775-1.38-1.380.79550.52250.38048.217.55106,432.80-68.51-29.43-113.88-35.6437.6839.59-180.11-110.250.2227-0.66790.2093--7.117.1759.77---22.73--
IMAC Holdings Inc0.00-5.63m1.93m2.00---------5.04-5.460.00-1.080.00--0.000.00-166.65-48.88-1,050.71-70.25-------97.63---14.97--------45.27------
Caremax Inc784.55m-782.86m2.54m1.45k------0.0032-208.41-208.41208.34-38.730.9776--6.10541,069.60-97.55---160.21---3.31---99.78-----1.951.57--19.01---1,707.99------
Greenbrook TMS Inc75.21m-52.20m2.63m629.00------0.035-1.20-1.201.72-2.711.33--8.73---93.25-68.51-206.71-106.4528.2738.65-70.09-76.82---1.9920.04--10.4228.2644.21---54.79--
Avalon Globocare Corp1.31m-14.73m2.82m5.00------2.16-19.56-19.561.674.940.0529--13.47261,792.00-59.51-100.94-96.64-134.5121.3324.44-1,125.62-1,011.06---0.32860.6162--4.45-4.28-40.03---51.83--
Mitesco Inc6.00k-4.15m3.29m3.00------548.75-0.6434-0.61210.0004-2.540.0332----2,000.00-1,094.48-246.54----0.00---33,009.50-29,214.62---0.7877---------59.12------
Syra Health Corp7.74m-4.25m3.71m78.00--1.11--0.4789-0.6471-0.64711.160.33962.20--7.9899,250.77-120.88---225.30--22.99---54.90-----5,665.830.0673---1.83---38.72------
Ethema Health Corp5.68m-2.13m3.86m65.00------0.6809-0.0005-0.00050.0012-0.00090.4666--10.6887,311.84-20.83-37.68-57.76-------44.64-94.87---2.33----10.8765.34652.41--74.97--
Selectis Health Inc38.30m-5.51m4.17m574.00------0.1089-1.80-1.8012.50-1.581.00--19.4866,719.06-14.37-3.03-26.50-3.58-----14.31-4.84---2.371.18---9.4058.97-64.93---47.72--
Data as of Nov 21 2024. Currency figures normalised to Avalon Globocare Corp's reporting currency: US Dollar USD

Institutional shareholders

1.19%Per cent of shares held by top holders
HolderShares% Held
Citadel Securities LLCas of 30 Sep 20242.54k0.24%
The Vanguard Group, Inc.as of 30 Sep 20242.30k0.22%
Geode Capital Management LLCas of 30 Sep 20242.14k0.20%
HRT Financial LP (US)as of 30 Sep 20241.80k0.17%
SSgA Funds Management, Inc.as of 30 Sep 20241.28k0.12%
Jane Street Capital LLCas of 30 Sep 2024924.000.09%
XTX Markets LLCas of 30 Sep 2024814.000.08%
UBS Securities LLCas of 30 Sep 2024604.000.06%
Tower Research Capital LLCas of 30 Sep 2024285.000.03%
Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 202413.000.00%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.